These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10585338)

  • 1. Biochemical and molecular genetic characteristics of the severe form of tyrosine hydroxylase deficiency.
    Bräutigam C; Steenbergen-Spanjers GC; Hoffmann GF; Dionisi-Vici C; van den Heuvel LP; Smeitink JA; Wevers RA
    Clin Chem; 1999 Dec; 45(12):2073-8. PubMed ID: 10585338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tyrosine hydroxylase deficiency: a case of autosomal recessive dopa-responsive dystonia].
    Tan D; Zhang Y; Ye J; Han L; Qiu W; Gu X; Zhang H
    Zhonghua Er Ke Za Zhi; 2014 Aug; 52(8):616-9. PubMed ID: 25224241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis.
    Willemsen MA; Verbeek MM; Kamsteeg EJ; de Rijk-van Andel JF; Aeby A; Blau N; Burlina A; Donati MA; Geurtz B; Grattan-Smith PJ; Haeussler M; Hoffmann GF; Jung H; de Klerk JB; van der Knaap MS; Kok F; Leuzzi V; de Lonlay P; Megarbane A; Monaghan H; Renier WO; Rondot P; Ryan MM; Seeger J; Smeitink JA; Steenbergen-Spanjers GC; Wassmer E; Weschke B; Wijburg FA; Wilcken B; Zafeiriou DI; Wevers RA
    Brain; 2010 Jun; 133(Pt 6):1810-22. PubMed ID: 20430833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain catecholamine depletion and motor impairment in a Th knock-in mouse with type B tyrosine hydroxylase deficiency.
    Korner G; Noain D; Ying M; Hole M; Flydal MI; Scherer T; Allegri G; Rassi A; Fingerhut R; Becu-Villalobos D; Pillai S; Wueest S; Konrad D; Lauber-Biason A; Baumann CR; Bindoff LA; Martinez A; Thöny B
    Brain; 2015 Oct; 138(Pt 10):2948-63. PubMed ID: 26276013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine hydroxylase deficiency with severe clinical course.
    Zafeiriou DI; Willemsen MA; Verbeek MM; Vargiami E; Ververi A; Wevers R
    Mol Genet Metab; 2009 May; 97(1):18-20. PubMed ID: 19282209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A common point mutation in the tyrosine hydroxylase gene in autosomal recessive L-DOPA-responsive dystonia in the Dutch population.
    van den Heuvel LP; Luiten B; Smeitink JA; de Rijk-van Andel JF; Hyland K; Steenbergen-Spanjers GC; Janssen RJ; Wevers RA
    Hum Genet; 1998 Jun; 102(6):644-6. PubMed ID: 9703425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype.
    Haugarvoll K; Bindoff LA
    J Parkinsons Dis; 2011; 1(1):119-22. PubMed ID: 23939262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and genetic characteristics of children with dopa-responsive dystonia caused by tyrosine hydroxylase gene variations].
    Zhang GY; Cai ZJ; Zhang XL; Yang L; Li YZ; Wei LK; Zhang YP; Chang PP; Zhu DN
    Zhonghua Er Ke Za Zhi; 2023 Apr; 61(4):339-344. PubMed ID: 37011980
    [No Abstract]   [Full Text] [Related]  

  • 9. Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene.
    Lüdecke B; Knappskog PM; Clayton PT; Surtees RA; Clelland JD; Heales SJ; Brand MP; Bartholomé K; Flatmark T
    Hum Mol Genet; 1996 Jul; 5(7):1023-8. PubMed ID: 8817341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and postnatal diagnosis of tyrosine hydroxylase deficiency.
    Møller LB; Romstad A; Paulsen M; Hougaard P; Ormazabal A; Pineda M; Blau N; Güttler F; Artuch R
    Prenat Diagn; 2005 Aug; 25(8):671-5. PubMed ID: 16049992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia.
    Hoffmann GF; Assmann B; Bräutigam C; Dionisi-Vici C; Häussler M; de Klerk JB; Naumann M; Steenbergen-Spanjers GC; Strassburg HM; Wevers RA
    Ann Neurol; 2003; 54 Suppl 6():S56-65. PubMed ID: 12891655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine hydroxylase deficiency in three Greek patients with a common ancestral mutation.
    Pons R; Serrano M; Ormazabal A; Toma C; Garcia-Cazorla A; Area E; Ribasés M; Kanavakis E; Drakaki K; Giannakopoulos A; Orfanou I; Youroukos S; Cormand B; Artuch R
    Mov Disord; 2010 Jun; 25(8):1086-90. PubMed ID: 20198643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in the tyrosine hydroxylase gene in the first Czech patient with tyrosine hydroxylase deficiency.
    Szentiványi K; Hansíková H; Krijt J; Vinšová K; Tesařová M; Rozsypalová E; Klement P; Zeman J; Honzík T
    Prague Med Rep; 2012; 113(2):136-46. PubMed ID: 22691284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetics of tyrosine 3-monooxygenase and inherited diseases.
    Kobayashi K; Nagatsu T
    Biochem Biophys Res Commun; 2005 Dec; 338(1):267-70. PubMed ID: 16105653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine hydroxylase deficiency: clinical manifestations of catecholamine insufficiency in infancy.
    Grattan-Smith PJ; Wevers RA; Steenbergen-Spanjers GC; Fung VS; Earl J; Wilcken B
    Mov Disord; 2002 Mar; 17(2):354-9. PubMed ID: 11921123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation.
    DE Lonlay P; Nassogne MC; van Gennip AH; van Cruchten AC; Billatte de Villemeur T; Cretz M; Stoll C; Launay JM; Steenberger-Spante GC; van den Heuvel LP; Wevers RA; Saudubray JM; Abeling NG
    J Inherit Metab Dis; 2000 Dec; 23(8):819-25. PubMed ID: 11196107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional studies of tyrosine hydroxylase missense variants reveal distinct patterns of molecular defects in Dopa-responsive dystonia.
    Fossbakk A; Kleppe R; Knappskog PM; Martinez A; Haavik J
    Hum Mutat; 2014 Jul; 35(7):880-90. PubMed ID: 24753243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetics of dopa-responsive dystonia.
    Ichinose H; Suzuki T; Inagaki H; Ohye T; Nagatsu T
    Biol Chem; 1999 Dec; 380(12):1355-64. PubMed ID: 10661862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of biochemical and molecular genetic aspects of tyrosine hydroxylase deficiency including a novel mutation (291delC).
    Wevers RA; de Rijk-van Andel JF; Bräutigam C; Geurtz B; van den Heuvel LP; Steenbergen-Spanjers GC; Smeitink JA; Hoffmann GF; Gabreëls FJ
    J Inherit Metab Dis; 1999 Jun; 22(4):364-73. PubMed ID: 10407773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical hallmarks of tyrosine hydroxylase deficiency.
    Bräutigam C; Wevers RA; Jansen RJ; Smeitink JA; de Rijk-van Andel JF; Gabreëls FJ; Hoffmann GF
    Clin Chem; 1998 Sep; 44(9):1897-904. PubMed ID: 9732974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.